Cell Communication and Signaling,
Journal Year:
2024,
Volume and Issue:
22(1)
Published: July 4, 2024
T
lymphocytes
play
a
primary
role
in
the
adaptive
antiviral
immunity.
Both
lymphocytosis
and
lymphopenia
were
found
to
be
associated
with
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
While
indicates
an
active
anti-viral
response,
is
sign
of
poor
prognosis.
T-cells,
essence,
rarely
express
ACE2
receptors,
making
cause
cell
depletion
enigmatic.
Moreover,
emerging
strains
posed
immunological
challenge,
potentially
alarming
for
next
pandemic.
Herein,
we
review
how
possible
indirect
direct
key
mechanisms
could
contribute
SARS-CoV-2-associated-lymphopenia.
The
fundamental
mechanism
inflammatory
cytokine
storm
elicited
by
viral
infection,
which
alters
host
metabolism
into
more
acidic
state.
This
"hyperlactic
acidemia"
together
suppresses
T-cell
proliferation
triggers
intrinsic/extrinsic
apoptosis.
SARS-CoV-2
infection
also
results
shift
from
steady-state
hematopoiesis
stress
hematopoiesis.
Even
low
expression,
presence
cholesterol-rich
lipid
rafts
on
activated
T-cells
may
enhance
entry
syncytia
formation.
Finally,
indicate
participation
other
receptors
or
auxiliary
proteins
that
can
work
alone
concert
mechanisms.
Therefore,
address
CD147-a
novel
route-for
its
new
variants.
CD147
not
only
expressed
but
it
interacts
co-partners
orchestrate
various
biological
processes.
Given
these
features,
appealing
candidate
pathogenicity.
Understanding
molecular
cellular
behind
SARS-CoV-2-associated-lymphopenia
will
aid
discovery
potential
therapeutic
targets
improve
resilience
our
immune
system
against
this
rapidly
evolving
virus.
Science Immunology,
Journal Year:
2022,
Volume and Issue:
7(75)
Published: Sept. 9, 2022
Lung-infiltrating
macrophages
create
a
marked
inflammatory
milieu
in
subset
of
patients
with
COVID-19
by
producing
cytokine
storm,
which
correlates
increased
lethality.
However,
these
are
largely
not
infected
SARS-CoV-2,
so
the
mechanism
underlying
their
activation
lung
is
unclear.
Type
I
interferons
(IFN-I)
contribute
to
protecting
host
against
SARS-CoV-2
but
may
also
have
some
deleterious
effect,
and
source
IFN-I
lungs
well
defined.
Plasmacytoid
dendritic
cells
(pDCs),
key
cell
type
involved
antiviral
responses,
can
produce
response
SARS-CoV-2.
We
observed
infiltration
pDCs
SARS-CoV-2–infected
patients,
correlated
strong
signaling
macrophages.
In
severe
COVID-19,
expressed
robust
signature,
persistent
at
single-cell
level.
Hence,
we
uncoupling
kinetics
associated
storm
that
were
dominant
IFN-α–producing
virus
blood,
whereas
produced
IFN-α
only
when
physical
contact
epithelial
cells.
showed
pDCs,
after
sensing
TLR7,
mediated
changes
both
transcriptional
epigenetic
levels,
favored
hyperactivation
environmental
stimuli.
Together,
data
indicate
priming
result
from
leading
macrophage
COVID-19.
Journal of Biomedical Science,
Journal Year:
2022,
Volume and Issue:
29(1)
Published: Oct. 26, 2022
Abstract
Severe
acute
respiratory
syndrome-associated
coronavirus-2
(SARS-CoV-2)
is
the
causal
agent
of
coronavirus
disease-2019
(COVID-19),
a
systemic
illness
characterized
by
variably
severe
pulmonary
symptoms,
cardiac
conduction
abnormalities,
diarrhea,
and
gastrointestinal
bleeding,
as
well
neurologic
deficits,
renal
insufficiency,
myalgias,
endocrine
other
perturbations
that
reflect
widespread
microvascular
injury
pro-inflammatory
state.
The
mechanisms
underlying
various
manifestations
viral
infection
are
incompletely
understood
but
most
data
suggest
COVID-19
results
from
virus-driven
in
immune
system
resultant
tissue
injury.
Aberrant
interferon-related
responses
lead
to
alterations
cytokine
elaboration
deplete
resident
cells
while
simultaneously
recruiting
hyperactive
macrophages
functionally
altered
neutrophils,
thereby
tipping
balance
adaptive
immunity
innate
immunity.
Disproportionate
activation
these
neutrophils
further
depletes
normal
activity
B-cells,
T-cells,
natural
killer
(NK)
cells.
In
addition,
this
state
stimulates
uncontrolled
complement
development
neutrophil
extracellular
traps
(NETS),
both
which
promote
coagulation
cascade
induce
“thrombo-inflammation”.
These
have
similar
multiple
organ
systems,
frequently
show
pathologic
findings
related
thrombosis
large
small
vessels.
However,
patients
with
generally
more
pronounced
than
those
organs.
Not
only
do
they
feature
inflammatory
thromboses
endothelial
injury,
much
parenchymal
damage
stems
failed
maturation
alveolar
pneumocytes,
interactions
between
type
2
pneumocytes
non-resident
macrophages,
greater
degree
NET
formation.
purpose
review
discuss
pathogenesis
can
occur
SARS-CoV-2
infection.
Understanding
important
future
therapies
for
COVID-19,
many
will
likely
target
specific
components
system,
particularly
induction,
cytokines,
subpopulations
Frontiers in Pharmacology,
Journal Year:
2022,
Volume and Issue:
13
Published: Sept. 7, 2022
Severe
acute
respiratory
syndrome
coronavirus
type
2
(SARS-CoV-2)
rapidly
infects
humans
and
animals
which
make
disease
2019
(COVID-19)
a
grievous
epidemic
worldwide
broke
out
in
2020.
According
to
data
analysis
of
the
other
family,
for
instance
severe
SARS
(SARS-CoV),
can
provide
experience
mutation
SARS-CoV-2
prevention
treatment
COVID-19.
Toll-like
receptors
(TLRs)
as
pattern
recognition
receptor
(PRRs),
have
an
indispensable
function
identifying
invader
even
activate
innate
immune
system.
It
is
possible
organism
different
TLR
pathways
leads
secretion
proinflammatory
cytokines
such
Interleukin
1
(IL-1),
6
(IL-6),
Tumor
necrosis
factor
α
(TNFα)
Ⅰ
interferon.
As
component
non-specific
immunity,
TLRs
pathway
may
participate
pathogenic
processes,
due
previous
works
proved
that
are
involved
invasion
infection
SARS-CoV
MERS
varying
degrees.
Different
TLR,
TLR2,
TLR4,
TLR7,
TLR8
TLR9
probably
double-sided
COVID-19
infection.
Therefore,
it
great
significance
correctly
acknowledging
how
take
part
will
be
development
strategies.
MedComm,
Journal Year:
2022,
Volume and Issue:
3(3)
Published: Aug. 1, 2022
The
2019
coronavirus
disease
(COVID-19)
pandemic
has
become
a
global
crisis.
In
the
immunopathogenesis
of
COVID-19,
SARS-CoV-2
infection
induces
an
excessive
inflammatory
response
in
patients,
causing
cytokine
storm
severe
cases.
Cytokine
leads
to
acute
respiratory
distress
syndrome,
pulmonary
and
other
multiorgan
failure,
which
is
important
cause
COVID-19
progression
even
death.
Among
them,
activation
pathways
major
factor
generating
storms
dysregulated
immune
responses,
closely
related
severity
viral
infection.
Therefore,
elucidation
signaling
pathway
providing
otential
therapeutic
targets
treatment
strategies
against
COVID-19.
Here,
we
discuss
pathogenesis
including
induction,
function,
downstream
signaling,
as
well
existing
potential
interventions
targeting
these
cytokines
or
pathways.
We
believe
that
comprehensive
understanding
regulatory
dysregulation
inflammation
will
help
develop
better
clinical
therapy
effectively
control
diseases,
such
Circulation Research,
Journal Year:
2023,
Volume and Issue:
132(10), P. 1272 - 1289
Published: May 11, 2023
COVID-19
is
characterized
by
dysregulated
thrombosis
and
coagulation
that
can
increase
mortality
in
patients.
Platelets
are
fast
responders
to
pathogen
presence,
alerting
the
surrounding
immune
cells
contributing
intravascular
coagulation.
The
SARS-CoV-2
genome
has
been
found
platelets
from
patients
with
COVID-19,
its
coverage
varies
according
method
of
detection,
suggesting
direct
interaction
virus
these
cells.
Antibodies
against
Spike
Nucleocapsid
have
confirmed
this
platelet-viral
interaction.
This
review
discusses
immune,
prothrombotic,
procoagulant
characteristics
observed
COVID-19.
We
outline
indirect
SARS-CoV-2,
contribution
programmed
cell
death
pathway
activation
consequent
extracellular
vesicle
release.
discuss
platelet
immunothrombosis
effect
on
platelets,
possible
classical
triggers
as
well
complement
activation.
As
COVID-19-mediated
still
not
understood
vivo,
we
available
murine
models
mouse
adaptable
strains.
Biology of Sex Differences,
Journal Year:
2023,
Volume and Issue:
14(1)
Published: Sept. 18, 2023
Human
endosomal
Toll-like
receptors
TLR7
and
TLR8
recognize
self
non-self
RNA
ligands,
are
important
mediators
of
innate
immunity
autoimmune
pathogenesis.
are,
respectively,
encoded
by
adjacent
X-linked
genes.
We
previously
established
that
evades
X
chromosome
inactivation
(XCI)
in
female
immune
cells.
Whether
also
XCI,
however,
has
not
yet
been
explored.
ACS Nano,
Journal Year:
2024,
Volume and Issue:
18(29), P. 18801 - 18833
Published: July 9, 2024
Tumor
vaccines,
an
important
part
of
immunotherapy,
prevent
cancer
or
kill
existing
tumor
cells
by
activating
restoring
the
body's
own
immune
system.
Currently,
various
formulations
vaccines
have
been
developed,
including
cell
membrane
DNA
mRNA
polypeptide
virus-vectored
and
tumor-in-situ
vaccines.
There
are
also
multiple
delivery
systems
for
such
as
liposomes,
vesicles,
viruses,
exosomes,
emulsions.
In
addition,
to
decrease
risk
escape
tolerance
that
may
exist
with
a
single
vaccine,
combination
therapy
radiotherapy,
chemotherapy,
checkpoint
inhibitors,
cytokines,
CAR-T
therapy,
photoimmunotherapy
is
effective
strategy.
Given
critical
role
in
here,
we
look
back
history
discuss
antigens,
adjuvants,
formulations,
systems,
mechanisms,
future
directions
Nature Neuroscience,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 6, 2025
COVID-19
is
associated
with
diverse
neurological
abnormalities,
but
the
underlying
mechanisms
are
unclear.
We
hypothesized
that
microglia,
resident
immune
cells
of
brain,
centrally
involved
in
this
process.
To
study
this,
we
developed
an
autopsy
platform
allowing
integration
molecular
anatomy,
protein
and
mRNA
datasets
postmortem
mirror
blocks
brain
peripheral
organ
samples
from
cases
COVID-19.
observed
focal
loss
microglial
P2Y12R,
CX3CR1-CX3CL1
axis
deficits
metabolic
failure
at
sites
virus-associated
vascular
inflammation
severely
affected
medullary
autonomic
nuclei
other
areas.
Microglial
dysfunction
linked
to
mitochondrial
injury
excessive
synapse
myelin
phagocytosis
glutamatergic
terminals,
line
proteomic
changes
assembly,
metabolism
neuronal
injury.
Furthermore,
regionally
heterogeneous
viral
load
central
systemic
related
interleukin
(IL)-1
or
IL-6
via
virus-sensing
pattern
recognition
receptors
inflammasomes.
Thus,
SARS-CoV-2-induced
might
lead
a
primarily
gliovascular
which
could
be
common
contributor
COVID-19-related
neuropathologies.